[vc_row][vc_column width=”2/3″][vc_row_inner][vc_column_inner][vc_column_text]
30th April, 2021 – Pfizer BionTech Receives NAFDAC Approval for Emergency Use Authorization
17th May, 2021 – NAFDAC grant conditional Emergency Use Authorization for Janssen COVID-19
[/vc_column_text][vc_empty_space height=”5px”][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][vc_column width=”1/3″][vc_column_text]
Approved Covid-19 Vaccines
[/vc_column_text][vc_column_text]18th February, 2021 – NAFDAC Approves ASTRAZENECA/OXFORD COVID-19 (COVISHIELD) VACCINE30th April, 2021 – Pfizer BionTech Receives NAFDAC Approval for Emergency Use Authorization
17th May, 2021 – NAFDAC grant conditional Emergency Use Authorization for Janssen COVID-19
[/vc_column_text][vc_empty_space height=”5px”][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]
Latest Updates on Covid-19 Safety and Monitoring
[/vc_column_text][vc_column_text]21th September, 2023 – Safety Signal Detection After Vaccination with COVID-19 Vaccines and Post Market Monitoring in Nigeria 26th June, 2021 – Safety Update For Covid-19 Vaccine Roll Out One: Astrazeneca (Covishield) – Introduction In Nigeria: Vol 001
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][vc_column width=”1/3″][vc_column_text]
Quick Links
[/vc_column_text][vc_wp_custommenu nav_menu=”98″][/vc_column][/vc_row]Quick Links
Covishield: Frequently Asked Questions
Janssen SmPC For Covid-19 Vaccines
Pfizer BioNTech SmPC For Covid-19 Vaccine
AstraZeneca SmPC For Covid-19 Vaccines
Moderna SmPC For COVID-19 Vaccine
Frequently Asked Questions (FAQs)
Was this helpful?
Thanks for your feedback!
